CORE & MAIN INC-CLASS A (CNM)

US21874C1027 - Common Stock

50.54  +0.41 (+0.82%)

Premarket: 52 +1.46 (+2.89%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNM. CNM was compared to 48 industry peers in the Trading Companies & Distributors industry. While CNM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNM is valied quite expensively at the moment, while it does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

CNM had positive earnings in the past year.
In the past year CNM had a positive cash flow from operations.
CNM had positive earnings in each of the past 5 years.
Of the past 5 years CNM 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.60%, CNM is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
CNM's Return On Equity of 24.54% is amongst the best of the industry. CNM outperforms 91.67% of its industry peers.
CNM has a better Return On Invested Capital (11.36%) than 77.08% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNM is above the industry average of 9.72%.
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROIC 11.36%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%

1.3 Margins

The Profit Margin of CNM (5.71%) is better than 62.50% of its industry peers.
In the last couple of years the Profit Margin of CNM has grown nicely.
CNM's Operating Margin of 9.93% is fine compared to the rest of the industry. CNM outperforms 64.58% of its industry peers.
CNM's Operating Margin has improved in the last couple of years.
CNM's Gross Margin of 26.63% is on the low side compared to the rest of the industry. CNM is outperformed by 64.58% of its industry peers.
In the last couple of years the Gross Margin of CNM has grown nicely.
Industry RankSector Rank
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNM is creating some value.
CNM has less shares outstanding than it did 1 year ago.
The debt/assets ratio for CNM is higher compared to a year ago.

2.2 Solvency

CNM has an Altman-Z score of 3.20. This indicates that CNM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.20, CNM is in line with its industry, outperforming 58.33% of the companies in the same industry.
The Debt to FCF ratio of CNM is 3.70, which is a good value as it means it would take CNM, 3.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNM (3.70) is better than 68.75% of its industry peers.
CNM has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CNM (1.43) is worse than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Altman-Z 3.2
ROIC/WACC1
WACC11.39%

2.3 Liquidity

A Current Ratio of 2.14 indicates that CNM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.14, CNM is in line with its industry, outperforming 54.17% of the companies in the same industry.
A Quick Ratio of 1.28 indicates that CNM should not have too much problems paying its short term obligations.
CNM's Quick ratio of 1.28 is in line compared to the rest of the industry. CNM outperforms 54.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.28

4

3. Growth

3.1 Past

The earnings per share for CNM have decreased by -3.42% in the last year.
Measured over the past years, CNM shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.95% on average per year.
CNM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.24%.
CNM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.92% yearly.
EPS 1Y (TTM)-3.42%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%-5.48%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%

3.2 Future

CNM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.59% yearly.
The Revenue is expected to grow by 6.32% on average over the next years.
EPS Next Y-4.22%
EPS Next 2Y1.42%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue Next Year10.84%
Revenue Next 2Y7.27%
Revenue Next 3Y6.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

CNM is valuated rather expensively with a Price/Earnings ratio of 22.36.
CNM's Price/Earnings is on the same level as the industry average.
CNM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 20.73, which indicates a rather expensive current valuation of CNM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNM is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.73. CNM is around the same levels.
Industry RankSector Rank
PE 22.36
Fwd PE 20.73

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNM is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
77.08% of the companies in the same industry are more expensive than CNM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.42
EV/EBITDA 13.87

4.3 Compensation for Growth

CNM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y1.42%
EPS Next 3Y6.59%

0

5. Dividend

5.1 Amount

No dividends for CNM!.
Industry RankSector Rank
Dividend Yield N/A

CORE & MAIN INC-CLASS A

NYSE:CNM (12/20/2024, 8:04:00 PM)

Premarket: 52 +1.46 (+2.89%)

50.54

+0.41 (+0.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)12-03 2024-12-03/bmo
Earnings (Next)N/A N/A
Inst Owners110.16%
Inst Owner Change-0.8%
Ins Owners0.35%
Ins Owner Change10.33%
Market Cap10.04B
Analysts77.5
Price Target52.33 (3.54%)
Short Float %6.49%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.55%
Min EPS beat(2)-10.01%
Max EPS beat(2)4.9%
EPS beat(4)3
Avg EPS beat(4)0.38%
Min EPS beat(4)-10.01%
Max EPS beat(4)6.32%
EPS beat(8)7
Avg EPS beat(8)3.93%
EPS beat(12)11
Avg EPS beat(12)10.94%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2%
Min Revenue beat(2)-5.49%
Max Revenue beat(2)1.49%
Revenue beat(4)2
Avg Revenue beat(4)-1%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)1.49%
Revenue beat(8)2
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.04%
EPS NQ rev (1m)-14.75%
EPS NQ rev (3m)-14.75%
EPS NY rev (1m)3.21%
EPS NY rev (3m)-5.25%
Revenue NQ rev (1m)-1.89%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)1.83%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 22.36
Fwd PE 20.73
P/S 1.4
P/FCF 15.42
P/OCF 14.77
P/B 6.01
P/tB N/A
EV/EBITDA 13.87
EPS(TTM)2.26
EY4.47%
EPS(NY)2.44
Fwd EY4.82%
FCF(TTM)3.28
FCFY6.48%
OCF(TTM)3.42
OCFY6.77%
SpS36.16
BVpS8.41
TBVpS-5.92
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 24.54%
ROCE 13.98%
ROIC 11.36%
ROICexc 11.38%
ROICexgc 25.83%
OM 9.93%
PM (TTM) 5.71%
GM 26.63%
FCFM 9.06%
ROA(3y)6.17%
ROA(5y)4.19%
ROE(3y)19.68%
ROE(5y)14.21%
ROIC(3y)12.93%
ROIC(5y)9.55%
ROICexc(3y)13.15%
ROICexc(5y)9.86%
ROICexgc(3y)32.43%
ROICexgc(5y)28.05%
ROCE(3y)15.91%
ROCE(5y)11.76%
ROICexcg growth 3Y10.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y41.37%
ROICexc growth 5YN/A
OM growth 3Y29.72%
OM growth 5Y20.79%
PM growth 3Y65.47%
PM growth 5Y37.09%
GM growth 3Y4%
GM growth 5Y4.17%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.7
Debt/EBITDA 2.66
Cap/Depr 15.76%
Cap/Sales 0.4%
Interest Coverage 4.54
Cash Conversion 75.81%
Profit Quality 158.78%
Current Ratio 2.14
Quick Ratio 1.28
Altman-Z 3.2
F-Score3
WACC11.39%
ROIC/WACC1
Cap/Depr(3y)18.52%
Cap/Depr(5y)14.68%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.42%
EPS 3Y108.01%
EPS 5Y60.95%
EPS Q2Q%-5.48%
EPS Next Y-4.22%
EPS Next 2Y1.42%
EPS Next 3Y6.59%
EPS Next 5YN/A
Revenue 1Y (TTM)8.24%
Revenue growth 3Y22.54%
Revenue growth 5Y15.92%
Sales Q2Q%11.55%
Revenue Next Year10.84%
Revenue Next 2Y7.27%
Revenue Next 3Y6.32%
Revenue Next 5YN/A
EBIT growth 1Y-4.93%
EBIT growth 3Y58.95%
EBIT growth 5Y40.02%
EBIT Next Year21.68%
EBIT Next 3Y13.13%
EBIT Next 5YN/A
FCF growth 1Y543.28%
FCF growth 3Y70.48%
FCF growth 5Y63.93%
OCF growth 1Y426.32%
OCF growth 3Y69.43%
OCF growth 5Y60.33%